Serotonin receptors in rat jugular vein: Presence and involvement in the contraction

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 1, 2010, Pages 116-123

  Linder, A Elizabeth ^b   Gaskell, Geri L ^a   Szasz, Theodora ^a   Thompson, Janice M ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLORO 3,4 DIMETHOXYBENZYL) 6 METHYL 1,2,3,4 TETRAHYDRO 9H PYRIDO [3,4 B] INDOLE HYDROCHLORIDE; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; KETANSERIN; MESSENGER RNA; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D AGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 3 AGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ISOMETRICS; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VENOCONSTRICTION;

ANIMALS; ENDOTHELIUM, VASCULAR; JUGULAR VEINS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 77953787696     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.163014     Document Type: Article

References (47)

1. Audia JE, Evrard DA, Murdoch GR, Droste JJ, Nissen JS, Schenck KW, Fludzinski P, Lucaites VL, Nelson DL, and Cohen ML (1996) Potent, selective tetrahydrobeta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus. J Med Chem 39:2773-2780.
2. Bailey AL, Scantlebury DC, and Smyth SS (2009) Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol 29:284-288.
3. Banes AK and Watts SW (2001) Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat. Hypertension 38:891-895.
4. Banes AK and Watts SW (2002) Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension. Hypertension 39:394-398.
5. Bax WA, Van Heuven-Nolsen D, Bos E, Simoons ML, and Saxena PR (1992) 5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins. Naunyn Schmiedebergs Arch Pharmacol 345:500-508.
6. Bhattacharya A, Schenck KW, Xu YC, Nisenbaum L, Galbreath E, and Cohen ML (2004) 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium. J Pharmacol Exp Ther 309:825-832.
7. Bodelsson M, Törnebrandt K, Bertilsson IL, and Arneklo-Nobin B (1992) Heterogeneity of contractile 5-HT receptors in human hand veins. Eur J Pharmacol 219: 455-460.
8. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, et al. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1:304-313.
9. Cohen ML, Fuller RW, and Wiley KS (1981) Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther 218:421-425. (Pubitemid 11044118)
10. Cortijo J, Martí-Cabrera M, Bernabeu E, Domènech T, Bou J, Fernández AG, Beleta J, Palacios JM, and Morcillo EJ (1997) Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies. Br J Pharmacol 122:1455-1463.
11. Cushing DJ and Cohen ML (1992) Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery. J Pharmacol Exp Ther 261:856-862.
12. Delesalle C, van Acker N, Claes P, Deprez P, de Smet I, Dewulf J, and Lefebvre RA (2008) Contractile effects of 5-hydroxytryptamine (5-HT) in the equine jejunum circular muscle: functional and immunohistochemical identification of a 5-HT1Alike receptor. Equine Vet J 40:313-320.
13. Ellis ES, Byrne C, Murphy OE, Tilford NS, and Baxter GS (1995) Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol 114:400-404.
14. Ficarelli E, Bernuzzi G, Tognetti E, Bussolati O, Zucchi A, Adorni D, and De Panfilis G (2008) Treatment of chronic venous leg ulcers by platelet gel. Dermatol Ther 21 (Suppl 1):S13-S17.
15. Gozlan H, El Mestikawy S, Pichat L, Glowinski J, and Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140-142. (Pubitemid 14235668)
16. Greenbaum D, Colangelo C, Williams K, and Gerstein M (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4:117.
17. Gul H, Yildiz O, Simsek A, Balkan M, Ersoz N, Cetiner S, Isimer A, and Sen D (2003) Pharmacologic characterization of contractile serotonergic receptors in human isolated mesenteric artery. J Cardiovasc Pharmacol 41:307-315.
18. Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, Chen X, Li L, Wu S, Chen Y, et al. (2008) How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 40:426-436.
19. Hile LM, Gibbons MD and Hile DC (2009) Lemierre syndrome complicating otitis externa: case report and literature review. J Emerg Med doi:10.1016/j.jemermed.2009.02.014.
20. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, and Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
21. Ishine T, Bouchelet I, Hamel E, and Lee TJ (2000) Serotonin 5-HT(7) receptors mediate relaxation of porcine pial veins. Am J Physiol Heart Circ Physiol 278: H907-H912. (Pubitemid 30152548)
22. Jähnichen S, Glusa E, and Pertz HH (2005) Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs. Naunyn Schmiedebergs Arch Pharmacol 371:89-98.
23. Kaumann AJ, Parsons AA, and Brown AM (1993) Human arterial constrictor serotonin receptors. Cardiovasc Res 27:2094-2103. (Pubitemid 24034717)
24. Kitka T and Bagdy G (2008) Effect of 5-HT2A/2B/2C receptor agonists and antagonists on sleep and waking in laboratory animals and humans, in Serotonin and Sleep: Molecular, Functional and Clinical Aspects (Monti JM, Pandi-Perumal SR, Jacobs BL, and Nutt DJ eds), Birkhäuser Verlag, Basel, Switzerland.
25. Kuhn DM, Wolf WA, and Lovenberg W (1980) Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension 2:243-255. (Pubitemid 10061127)
26. Lim CS, Gohel MS, and Davies AH (2008) Is there still a role for basic science research in venous disease? Phlebology 23:147-148.
27. Linder AE, Beggs KM, Burnett RJ, and Watts SW (2009) Body distribution of infused serotonin in rats. Clin Exp Pharmacol Physiol 36:599-601.
28. Linder AE, Ni W, Szasz T, Burnett R, Diaz J, Geddes TJ, Kuhn DM, and Watts SW (2008) A serotonergic system in veins: serotonin transporter- independent uptake. J Pharmacol Exp Ther 325:714-722.
29. McKune CM and Watts SW (2001) Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling. J Pharmacol Exp Ther 297:88-95.
30. McMullan R, McConville C, Clarke JC, Adams DA, and Hedderwick S (2004) Lemierre syndrome: remember the forgotten disease. Ulster Med J 73:123-125. (Pubitemid 40074396)
31. Morecroft I, Heeley RP, Prentice HM, Kirk A, and MacLean MR (1999) 5-Hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor. Br J Pharmacol 128:730-734.
32. Ni W, Geddes TJ, Priestley JR, Szasz T, Kuhn DM, and Watts SW (2008) The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. Br J Pharmacol 154:663-674.
33. Nilsson T, Longmore J, Shaw D, Pantev E, Bard JA, Branchek T, and Edvinsson L (1999) Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol 372:49-56.
34. Pascarella L, Schmid-Schönbein GW, and Bergan J (2005) An animal model of venous hypertension: the role of inflammation in venous valve failure. J Vasc Surg 41:303-311.
35. Rapport MM, Green AA, and Page IH (1948) Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem 176:1243-1251.
36. Russell A, Banes A, Berlin H, Fink GD, and Watts SW (2002) 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat. J Pharmacol Exp Ther 303:179-187.
37. Schachner T, Laufer G, and Bonatti J (2006) In vivo (animal) models of vein graft disease. Eur J Cardiothorac Surg 30:451-463.
38. 2 agonist radioligand. Biochem Pharmacol 36:3265-3271.
39. Ullmer C, Schmuck K, Kalkman HO, and Lübbert H (1995) Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370:215-221.
40. Vialli M and Erspamer V (1937) Ricerche sul secreto delle cellule enterocromaffini. Cell Tissue Res 27:81-99.
41. Villalón CM and Centurión D (2007) Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications. Naunyn Schmiedebergs Arch Pharmacol 376:45-63.
42. Wacker MJ and Godard MP (2005) Analysis of one-step and two-step real-time RT-PCR using SuperScript III. J Biomol Tech 16:266-271.
43. Watts SW (2002) Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension 39:825-829.
44. Watts SW and Cohen ML (1999) Vascular 5-HT receptors: pharmacology and pathophysiology of 5-HT1B, 5-HT1D, 5-HT1F, 5-HT2B and 5-HT7 receptors. Neurotransmissions 15:3-15.
45. Watts SW and Thompson JM (2004) Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. J Pharmacol Exp Ther 309:165-172.
46. Watts SW, Yang P, Banes AK, and Baez M (2001) Activation of Erk mitogenactivated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol 38:539-551.
47. Yildiz O, Gul H, Ozgok Y, Onguru O, Kilciler M, Aydin A, Isimer A, and Harmankaya AC (2003) Increased vasoconstrictor reactivity and decreased endothelial function in high grade varicocele; functional and morphological study. Urol Res 31:323-328.